Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) corresponding to Human Smad4 aa 500 to the C-terminus (C terminal).
Positive control
WB: NIH/3T3, PC-12, Ramos and SH-SY5Y cell lysates. IHC-P: human lung carcinoma and breast carcinoma tissues. ICC/IF: HeLa cells. Flow Cyt: A431 and SH-SY5Y cells.
General notes
We are constantly working hard to ensure we provide our customers with best in class antibodies. As a result of this work we are pleased to now offer this antibody in purified format. We are in the process of updating our datasheets. The purified format is designated ‘PUR’ on our product labels. If you have any questions regarding this update, please contact our Scientific Support team.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.